Author

Craig S. Lammert

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Safety and efficacy of zetomipzomib in relapsed or insufficiently responding autoimmune hepatitis: Results from the randomized, double-blind, placebo-controlled, phase 2a PORTOLA study and open-label extension.

BACKGROUND AND AIMS Autoimmune hepatitis (AIH) is a chronic immune-mediated liver disease with limited treatments and a need for glucocorticoid-sparing therapies. Zetomipzomib is a selective immunoproteasome inhibitor in development for AIH. APPROACH AND RESULTS PORTOLA was a randomized, double-blind, placebo-control...

Craig S. Lammert, Ethan M. Weinberg, Seth N. Sclair et al. · Hepatology · 0 citations

Review Open access Sep 2026

Bidirectional Psychosocial Burden in Autoimmune Hepatitis: Mental Health, Caregiver Strain, and the Potential Role of Patient Advocacy Programming.

BACKGROUND Autoimmune hepatitis (AIH) is associated with substantial psychosocial burden, yet mental health challenges remain poorly characterized and caregiver experience has not been systematically described. AIMS We aimed to (1) characterize mental health burden among AIH patients; (2) provide the first systematic...

Elizabeth Gentry, A. M. Montero, Nadia Blessing et al. · Digestive Diseases and Scien... · 0 citations